EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 56 days ( -0.761 % )
Last Price $3.97 0 %
High/ Low $3.97 - $3.97 -5.29%
Chg 7 Days -5.02 % $4.18 $3.97
Chg 30 Days -9.77 % $4.40 $3.97
Chg 12 mos 9.37 % $3.63 $3.97
Trend - 3 mos 5.60 % Width: 13.10 %
Trend - 12 mos 26.66 % Width: 17.53 %
Pred. range - 3 mos $4.20 - $4.75 5.70 % - 19.55 %
Pred. range - 12 mos $5.03 - $5.92 26.78 % - 49.00 %
Short MA avg 3 mos Sell May 30, 2024 - 18 days
Long MA avg 3 mos Sell Jun 03, 2024 - 16 days
Short/Long MA avg 3 mos Sell Jun 05, 2024 - 14 days
Short MA avg 12 mos Sell Jun 03, 2024 - 16 days
Long MA avg 12 mos Sell Jun 21, 2024 - 3 days
Short/Long MA avg 12 mos Buy Apr 17, 2024 - 48 days
Pivot Short Buy May 22, 2024 - 23 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma... KHTRF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT